Title

AWS re:Invent 2022 - How Intel & AWS solve some of the world’s most urgent issues (PRT278)

Summary

Akanksha, the alliance leader for AWS at Intel APJ and global HPC and AI strategy lead, introduces the session focused on the impact of cloud technology on life, particularly through high-performance computing (HPC).
Intel has been customizing silicon for AWS Cloud for 17 years, with a strong focus on HPC, which is now widely adopted across industries.
AWS Parallel Cluster is part of the Intel Select Solutions catalog, and Intel has earned the HPC partner competency badge.
Intel Xeon Scalable Processors are customized for AWS, including the newly announced HPC6ID instance.
HPC democratization is highlighted, with examples from various sectors such as healthcare, weather prediction, and automotive.
Intel and AWS have initiated a social impact computing program to support projects in conservation, sustainability, and education.
Tanner Marsh from Harvard Cancer Center discusses Virtual Flow, a project for democratizing drug discovery using AWS and Intel's HPC capabilities.
A representative from Good Chemistry presents their work on accelerating materials design for environmental challenges using cloud-based HPC.
Nicolas Douille from ICTOS shares their collaboration with Medicines for Malaria Venture to accelerate drug discovery against malaria using AI and AWS technologies.
The session emphasizes the importance of collaboration between Intel and AWS in driving social impact through technology, with a focus on performance, cost reduction, and scalability.

The partnership between Intel and AWS has been longstanding and is deeply integrated, focusing on optimizing cloud solutions for HPC workloads.
HPC is no longer confined to academia and research institutions; it has become a critical tool across various industries, enabling complex simulations and data analysis.
Cloud computing, particularly AWS, has enabled the democratization of HPC, allowing smaller organizations and individuals to access powerful computing resources without the need for large-scale infrastructure investments.
The Virtual Flow project at Harvard represents a significant advancement in drug discovery, leveraging cloud-based HPC to screen billions of compounds rapidly and cost-effectively.
Good Chemistry's work on tackling environmental issues like PFAS contamination demonstrates the potential of cloud-based HPC to address large-scale, complex problems that were previously intractable.
ICTOS's use of AI and cloud computing to accelerate drug discovery for malaria showcases the potential for technology to have a significant social impact, particularly in non-profit and resource-constrained settings.
The success stories presented highlight the transformative power of cloud computing and HPC in solving real-world problems and the potential for these technologies to contribute to global challenges such as health, sustainability, and environmental protection.